Andrographis Paniculate P. E.
You May Also Be Interested In:
Now we can supply the Andrographis Paniculate P. E. with the following specification:
Andrographolide 5-98% Min (HPLC)
Dehydroandrographolide 5-95% Min (HPLC)
Deoxyandrographolide 98% Min (HPLC)
Neoandrographolide 98% Min (HPLC)
Andrographolide, the main active constituent of A. paniculata, given by oral route, possessed dose-dependent (3-12 mg/kg) activity in rats against galactosamine - induced hepatic damage. Hepatoprotective activity in isolated rat hepatocytes (ex-vivo) was assessed by observing an increase in the viability and rate of oxygen consumption. Anticholestatic effect was indicated by an increase in bile flow and by the normalization of its contents (bile salts and bile acids) . Andrographolide was found to be slightly more active than silymarin, a known hepatoprotective drug.
At the same time, the study of The protective effect of Andrograhis paniculata and andrographolide (ANDLE) against cyclophosphamide (CTX) -induced urothelial toxicity is going on.